The stock of Altimmune Inc (NASDAQ:ALT) last traded at $8.40, up 4.41% from the previous session.
ALT stock price is now 18.54% away from the 50-day moving average and 10.84% away from the 200-day moving average. The market capitalization of the company currently stands at $597.80M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $26, UBS recently initiated with Buy rating for Altimmune Inc (NASDAQ: ALT). , while ‘Goldman’ rates the stock as ‘Neutral’
In other news, Drutz David, Director sold 16,011 shares of the company’s stock on Aug 19 ’24. The stock was sold for $110,547 at an average price of $6.90. Upon completion of the transaction, the Director now directly owns 41,958 shares in the company, valued at $0.35 million. A total of 0.83% of the company’s stock is owned by insiders.
During the past 12 months, Altimmune Inc has had a low of $2.48 and a high of $14.84. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 16.87, and a quick ratio of 16.87. The fifty day moving average price for ALT is $7.0644 and a two-hundred day moving average price translates $7.593 for the stock.
The latest earnings results from Altimmune Inc (NASDAQ: ALT) was released for 2024-09-30. The net profit margin was -199076.92% and return on equity was -72.96% for ALT. The company reported revenue of $5000.0 for the quarter, compared to $0.36 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -98.62 percent. For the current quarter, analysts expect ALT to generate $620 in revenue.
